首页> 美国卫生研究院文献>Clinical Translational Immunology >Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases
【2h】

Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases

机译:拥抱肠道菌群:炎性和传染性疾病的新领域

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The gut microbiota provides essential signals for the development and appropriate function of the immune system. Through this critical contribution to immune fitness, the gut microbiota has a key role in health and disease. Recent advances in the technological applications to study microbial communities and their functions have contributed to a rapid increase in host–microbiota research. Although it still remains difficult to define a so-called ‘normal' or ‘healthy' microbial composition, alterations in the gut microbiota have been shown to influence the susceptibility of the host to different diseases. Current translational research combined with recent technological and computational advances have enabled in-depth study of the link between microbial composition and immune function, addressing the interplay between the gut microbiota and immune responses. As such, beneficial modulation of the gut microbiota is a promising clinical target for many prevalent diseases including inflammatory bowel disease, metabolic abnormalities such as obesity, reduced insulin sensitivity and low-grade inflammation, allergy and protective immunity against infections.
机译:肠道菌群为免疫系统的发育和适当的功能提供了必要的信号。通过对免疫适应性的这一重要贡献,肠道菌群在健康和疾病中具有关键作用。研究微生物群落及其功能的技术应用的最新进展促进了宿主-微生物群研究的迅速增加。尽管仍然难以定义所谓的“正常”或“健康”微生物组成,但肠道菌群的改变已显示出会影响宿主对不同疾病的敏感性。当前的转化研究与最新的技术和计算进展相结合,使得能够深入研究微生物组成与免疫功能之间的联系,解决肠道菌群与免疫反应之间的相互作用。因此,对肠道菌群的有益调节是许多流行疾病的有希望的临床目标,这些疾病包括炎性肠病,代谢异常(例如肥胖症),胰岛素敏感性降低和低度炎症,过敏和针对感染的保护性免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号